Tag Archives: cardiomyopathies

EACVI 2025 strengthens multi-modality imaging expertise with advanced training, guideline updates and AI-driven insights

(IN BRIEF) The European Association of Cardiovascular Imaging will host EACVI 2025 in Vienna from 11–13 December, bringing together echocardiography, CMR, CT and nuclear cardiology within a unified multi-modality congress. The event will highlight advances in individual imaging techniques as … Read the full press release

Transthyretin amyloid cardiomyopathy: Alexion granted an exclusive worldwide licence to develop, manufacture and commercialise NI006 as part of an agreement with Neurimmune AG

Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition (PRESS RELEASE) CAMBRIDGE, 7-Jan-2022 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced … Read the full press release

Sanofi and MyoKardia, Inc. join forces to discover and develop first-of-its-kind targeted therapeutics for heritable heart diseases known as cardiomyopathies

Up to $200 Million Collaboration to Support Pioneering Science and New Treatments Paris and South San Francisco, CA, 18-9-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic … Read the full press release